The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Permeation enhancer strategies in transdermal drug delivery
Open accessAbstract
Today, ∼74% of drugs are taken orally and are not found to be as effective as desired. To improve such characteristics, transdermal drug delivery was brought to existence. This delivery system is capable of transporting the drug or macromolecules painlessly through skin into the blood circulation at fixed rate. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive techniques of drug delivery. Several important advantages of transdermal drug delivery are prevention from hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. Human skin surface, as a site of drug application for both local and systemic effects, is the most eligible candidate available. New controlled transdermal drug delivery systems (TDDS) technologies (electrically-based, structure-based and velocity-based) have been developed and commercialized for the transdermal delivery of troublesome drugs. This review article covers most of the new active transport technologies involved in enhancing the transdermal permeation via effective drug delivery system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Scaffold: A Novel Carrier for Cell and Drug Delivery
Garg, T., Singh, O., Arora, S., & Murthy, R. S. R. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i1.10 · Cited by 549
Self-citationSkin permeabilization for transdermal drug delivery: recent advances and future prospects
Schoellhammer, C. M., Blankschtein, D., & Langer, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.875528 · Cited by 376
Effect of liposomes and niosomes on skin permeation of enoxacin
Fang, J.-Y., Hong, C.-T., Chiu, W.-T., & Wang, Y.-Y. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00627-5 · Cited by 309
Recent advances in gel technologies for topical and transdermal drug delivery
Rehman, K., & Zulfakar, M. H. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.828219 · Cited by 266
Formulation and evaluation of ethosomes for transdermal delivery of lamivudine
Jain, S., Tiwary, A. K., Sapra, B., & Jain, N. K. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804111 · Cited by 254
Dubey, V., Mishra, D. K., & Jain, N. K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.007 · Cited by 228
Desai, P. R., Marepally, S., Patel, A. R., Voshavar, C., Chaudhuri, A., & Singh, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.021 · Cited by 188
Brown, L. R., & Langer, R. (1988) · Annual Review of Medicine · doi:10.1146/annurev.me.39.020188.001253 · Cited by 182
Iontophoresis: A Potential Emergence of a Transdermal Drug Delivery System
Dhote, V. (2012) · Scientia Pharmaceutica · doi:10.3797/scipharm.1108-20 · Cited by 175
Two-Layered Dissolving Microneedles for Percutaneous Delivery of Peptide/Protein Drugs in Rats
Fukushima, K., Ise, A., Morita, H., Hasegawa, R., Ito, Y., Sugioka, N., & Takada, K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0097-7 · Cited by 171
Liposomal Delivery System Enhances Anti-Inflammatory Properties of Curcumin
Basnet, P., Hussain, H., Tho, I., & Škalko‐Basnet, N. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22785 · Cited by 171
Biomaterial-based scaffolds – current status and future directions
Garg, T., & Goyal, A. K. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.891014 · Cited by 165
Self-citationComprehensive review on additives of topical dosage forms for drug delivery
Garg, T., Rath, G., & Goyal, A. K. (2015) · Drug Delivery · doi:10.3109/10717544.2013.879355 · Cited by 161
Self-citationDevelopment and characterization of nano-fiber patch for the treatment of glaucoma
Gagandeep, Garg, T., Malik, B., Rath, G., & Goyal, A. K. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.016 · Cited by 158
Self-citationTransdermal absorption enhancement through rat skin of gallidermin loaded in niosomes
Manosroi, A., Khanrin, P., Lohcharoenkal, W., Werner, R. G., Götz, F., Manosroi, W., & Manosroi, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.064 · Cited by 146
El‐Moslemany, R. M., Abdallah, O. Y., El-Khordagui, L. K., & Khalafallah, N. M. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9783-6 · Cited by 143
Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles
Ham, A. S., Cost, M. R., Sassi, A. B., Dezzutti, C. S., & Rohan, L. C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9765-2 · Cited by 136
Romero, E. L., & Morilla, M. J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s33048 · Cited by 130
Stimuli-Sensitive Hydrogels: An Excellent Carrier for Drug and Cell Delivery
Garg, T., Singh, S., & Goyal, A. K. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013007259 · Cited by 129
Self-citationTopical delivery of hyaluronic acid into skin using SPACE-peptide carriers
Chen, M., Gupta, V., Anselmo, A. C., Muraski, J. A., & Mitragotri, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.007 · Cited by 128
Cell-cell interactions during transendothelial migration of tumor cells
Voura, E. B., Sandig, M., & Siu, C. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981101)43:3<242::aid-jemt6>3.0.co;2-g · Cited by 121
Engineering Nanomedicines for Improved Melanoma Therapy: Progress and Promises
Bei, D., Meng, J., & Youan, B.-B. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.117 · Cited by 104
Kaur, M., Malik, B., Garg, T., Rath, G., & Goyal, A. K. (2014) · Drug Delivery · doi:10.3109/10717544.2014.894594 · Cited by 98
Self-citationGarg, T. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.916715 · Cited by 97
Self-citationLiposomes: Targeted and Controlled Delivery System
Garg, T., & Goyal, A. K. (2013) · Drug Delivery Letters · doi:10.2174/22103031113036660015 · Cited by 97
Self-citationNanoparticles as a Novel Delivery Vehicle for Therapeutics Targeting Erectile Dysfunction
Han, G., Tar, M., Kuppam, D., Friedman, A., Melman, A., Friedman, J. M., & Davies, K. P. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01507.x · Cited by 75
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Ghaffarian, R., & Muro, S. (2013) · Journal of Visualized Experiments · doi:10.3791/50638 · Cited by 72
Eriksson, F., Tötterman, T. H., Maltais, A.-K., Pisa, P., & Yachnin, J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.063 · Cited by 68
Lowered Humidity Produces Human Epidermal Equivalents with Enhanced Barrier Properties
Sun, R. K. P., Celli, A., Crumrine, D. A., Hupe, M., Adame, L., Pennypacker, S. D., Park, K., Uchida, Y., Feingold, K. R., Elias, P. M., et al. (2014) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2014.0065 · Cited by 53
Kim, S. T., Lee, K., Park, H., Jin, S., Ahn, W. S., & Kim, C. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1268 · Cited by 52
In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A
Cao, J., Guo, L., Wan, B., & Wei, Y. (2011) · Journal of Environmental Sciences · doi:10.1016/s1001-0742(10)60408-1 · Cited by 49
Barker, D. J., Bercovicz, D., Servilio, L. C., Simmons, S. J., Ma, S., Root, D. H., Pawlak, A. P., & West, M. O. (2013) · Addiction Biology · doi:10.1111/adb.12044 · Cited by 30
A fundamental investigation into the effects of eutectic formation on transmembrane transport
Fiala, S., Jones, S. A., & Brown, M. B. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.001 · Cited by 28
Kim, J., Jang, J., Lee, J. H., Choi, J. K., Park, W.-R., Bae, I., Bae, J., & Park, J. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0729-1 · Cited by 27
Potential use of iontophoresis for transdermal delivery of NF-κB decoy oligonucleotides
Hashim, I. I. A., Motoyama, K., Abd-Elgawad, A.-E. H., El-Shabouri, M. H., Borg, T. M., & Arima, H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.020 · Cited by 21
Nanotechnological Approaches for Genetic Immunization
Goyal, A. K., Rath, G., & Garg, T. (2013) · RNA technologies · doi:10.1007/978-3-642-36853-0_4 · Cited by 21
Self-citationNanotechnological Approaches for Genetic Immunization
Goyal, A. K., Rath, G., & Garg, T. (2013) · Springer eBooks · doi:10.1007/978-3-662-45775-7_4 · Cited by 21
Self-citationMeloxicam transdermal delivery: effect of eutectic point on the rate and extent of skin permeation.
Mohammadi‐Samani, S., Yousefi, G., Mohammadi, F., & Ahmadi, F. (2014) · Europe PMC (PubMed Central) · Cited by 20
Cited by
Cyclodextrins: structure, physicochemical properties and pharmaceutical applications
Jansook, P., Ogawa, N., & Loftsson, T. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.018 · Cited by 811
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Recent advancements in liposome technology
Filipczak, N., Pan, J., Yalamarty, S. S. K., & Torchilin, V. P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.022 · Cited by 592
Overcoming skin barriers through advanced transdermal drug delivery approaches
Phatale, V., Vaiphei, K. K., Jha, S., Patil, D., Agrawal, M., & Alexander, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.025 · Cited by 482
Recent advances in polymeric transdermal drug delivery systems
Sabbagh, F., & Kim, B. S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.025 · Cited by 368
Metadata
- Authors
- Marwah, H., Garg, T., Goyal, A. K., & Rath, G.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2014-07-09
- Volume
- 23
- Issue
- 2
- Pages
- 564-578
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2162853758
- Cited by
- 529
- References
- 39
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.